Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
DentScribe has received a Notice of Allowance from the United States Patent and Trademark Office for its first U.S. patent application covering an AI system that automates dental clinical documentation, including real-time speech capture, transcription, and structured data extraction.
Senhwa Biosciences has signed a strategic MOU with Y Combinator-backed biotech firm CellType to integrate AI into the development of its oncology drug CX-4945, aiming to expand its therapeutic potential and accelerate clinical progress.
Procode AI has emerged from stealth with $4 million in funding and the acquisition of The Auctus Group, aiming to bring AI-powered revenue cycle management to private practice surgeons.
Droplet Biosciences is using NVIDIA's GPU-accelerated Parabricks software to reduce cancer genomic analysis times from days to hours, enabling faster post-surgery diagnostics.
Lyfegen has launched its AI Contracting Companion, designed to help pharmaceutical organizations manage complex global pricing and contracting decisions through an integrated, AI-supported framework.
Ease Health has emerged from stealth with a $41 million Series A funding round led by Andreessen Horowitz to develop an AI-native operating system that integrates CRM, EHR, and RCM for behavioral health providers.
Dutch AI healthcare platform Delphyr has secured €1.75 million in funding from investors including the founders of Hugging Face and DEGIRO to enhance its AI agents that reduce administrative tasks for medical professionals.
DarcyIQ has launched native integrations with Epic and athenahealth’s EHR platforms, enabling AI-powered automation for clinical and operational workflows, according to a press release.
Guideway Care has acquired Waypoint Healthcare Solutions to enhance its Enterprise Evidence-Based Patient Activation Intelligence platform, integrating AI and virtual agent tools to improve patient engagement and operational efficiency.
Perimeter Medical Imaging AI has received FDA premarket approval for Claire, the first AI-enabled imaging device approved in the U.S. for intraoperative breast cancer margin assessment. The device uses optical coherence tomography and AI to help surgeons detect hidden cancer tissue during breast-conserving surgery.
Gene Solutions has announced its entry into Türkiye at the 2nd International Hereditary Cancers Congress, showcasing real-world evidence and ctDNA-powered oncology solutions developed with ATC Genomics.
DentScribe has introduced an expanded version of its agentic AI platform that converts real-time chairside conversations into structured SOAP notes and integrates them directly into dental practice systems.
Grow Therapy has raised $150 million in Series D funding led by TCV and Goldman Sachs Alternatives, with participation from BCI and Menlo Ventures. The company plans to expand its AI-assisted tools, partnerships with insurers and employers, and integrations with health systems.
Elsevier has introduced Osmosis AI, an AI-powered study companion that integrates verified medical content, Osmosis videos, and conversational AI to support medical students and educators.
Kyndryl and the University of Liverpool have announced a collaboration to develop AI-driven healthcare technologies using Kyndryl’s Agentic AI Framework and the university’s research expertise. The partnership will focus on creating blueprints for next-generation healthcare systems, including conversational AI tools to enhance patient interaction and data use.
ArisGlobal has launched XDI, a federated data intelligence platform designed to unify and analyze life sciences data across domains, enabling explainable decision-making at scale.
Angelini Pharma and Quiver Bioscience have entered a multi-year research and licensing agreement to develop AI-driven therapies for genetic epilepsies. The partnership grants Angelini exclusive global rights to future drug targets identified through Quiver’s platform.
Turbine has raised $25 million in Series B funding led by Interactive Venture Partners, with participation from Beiersdorf Venture Capital and others. The company also announced its first immunology collaboration with a top 10 pharmaceutical firm to model immune cell behavior using AI-driven virtual assays.
Turbine has raised $25 million in Series B funding led by Interactive Venture Partners, with participation from Beiersdorf Venture Capital and others. The company also announced a new immunology partnership with a top 10 pharmaceutical company to expand its AI-driven virtual cell platform.
MediKarma reported that its Agentic AI platform achieved a 50% A1C improvement rate in a 120-day study with Dallas Endocrinology, leading to a 20,000-unit deployment with Family Health Choice.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
